Japan Medical Dynamic Marketing (7600) Fundamentals 2026 — P/E 94.3x, Revenue Analysis | SniperIQ
Japan Medical Dynamic Marketing (7600) is a JP-listed Healthcare company in Medical - Devices with a market capitalization of ¥24.8B, trading at ¥941.00 on the JPX. This SniperIQ fundamentals page covers Japan Medical Dynamic Marketing's valuation (P/E 94.3x, P/B 1.0x), profitability (net margin 1.1%), revenue (¥23.9B in FY2025), balance-sheet quality, and AI signal context — from live market data, research only.
Full research coverage
- 8-Quarter Revenue & Margin Trend
- Debt Maturity & Coverage
- Peer Valuation Comparison
- Free Cash Flow & Owner Earnings
- AI Signal + Institutional Flow
- DCF Valuation Model
Frequently Asked Questions
What is Japan Medical Dynamic Marketing's market cap?
Japan Medical Dynamic Marketing (7600) has a market capitalization of approximately ¥24.8B, trading at ¥941.00 on the JPX. Market cap moves with the live share price.
What is Japan Medical Dynamic Marketing's P/E ratio?
Japan Medical Dynamic Marketing's trailing twelve-month P/E ratio is 94.3x, with a price-to-book (P/B) of 1.0x. Valuation multiples are best compared with Healthcare sector peers rather than read in isolation.
How profitable is Japan Medical Dynamic Marketing?
Japan Medical Dynamic Marketing runs a net profit margin of 1.1%, a gross margin of 53.3%, and an operating margin of 2.4%. Margins and ROE indicate how efficiently the business converts sales into profit and shareholder returns.
How much revenue does Japan Medical Dynamic Marketing generate?
Japan Medical Dynamic Marketing reported revenue of ¥23.9B for fiscal year 2025, with net income of ¥263M and earnings per share (EPS) of 9.99. SniperIQ tracks the full 8-quarter revenue and margin trend on the research dashboard.
Does Japan Medical Dynamic Marketing pay a dividend?
Japan Medical Dynamic Marketing offers a trailing dividend yield of about 1.8%. Dividend sustainability depends on payout ratio, free cash flow, and earnings stability — all tracked in SniperIQ's fundamentals view.
Is Japan Medical Dynamic Marketing financially healthy?
Japan Medical Dynamic Marketing carries a debt-to-equity ratio of 0.23x and a current ratio of 3.23x, with a market beta of 0.76. Lower leverage and a current ratio above 1.0 generally signal a stronger balance sheet.
Is Japan Medical Dynamic Marketing a good stock to buy in 2026?
SniperIQ provides research-only market intelligence, not personalised financial advice or a buy/sell call. For Japan Medical Dynamic Marketing (7600) the key facts are: market cap ¥24.8B, P/E 94.3x, revenue ¥23.9B, 52-week range 445-1005. Weigh valuation, profitability, growth, and balance-sheet strength against Healthcare peers and form your own view.
Track Japan Medical Dynamic Marketing's full fundamentals live
Get Japan Medical Dynamic Marketing's 8-quarter revenue and margin trend, peer comparison, DCF model, and AI signal on the SniperIQ research dashboard.